BioMarker Strategies
Biomarker Strategies is a company dedicated to advancing biomarker research and development. Their mission is to provide innovative solutions and expertise in biomarker discovery, validation, and commercialization to support personalized medicine and improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
BioMarker Strategies
1234 Research Ave, Science City, SC 56789
Patents
Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
US-9766249-B2
View Details
Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
US-9766249-B2
View DetailsProducts
SnapPath Cancer Diagnostics System
A diagnostics system that automates the processing of live solid tumor cells from fresh samples for ex vivo exposure to targeted therapies, enabling the generation of PathMAP Functional Signaling Profiles.
PathMAP Functional Signaling Profiles
Biomarker tests that provide predictive information on individual response to targeted treatments for solid tumors, based on the dynamic response of live cell signaling pathways.
SnapPath Cancer Diagnostics System
A diagnostics system that automates the processing of live solid tumor cells from fresh samples for ex vivo exposure to targeted therapies, enabling the generation of PathMAP Functional Signaling Profiles.
PathMAP Functional Signaling Profiles
Biomarker tests that provide predictive information on individual response to targeted treatments for solid tumors, based on the dynamic response of live cell signaling pathways.
Services
Consulting on biomarker selection, translational strategy, and alignment with clinical development goals.
Development and analytical validation of biomarker assays to predefined performance criteria.
Support for incorporating biomarkers into clinical protocols, including sampling plans and endpoint definitions.
Consulting on biomarker selection, translational strategy, and alignment with clinical development goals.
Development and analytical validation of biomarker assays to predefined performance criteria.
Support for incorporating biomarkers into clinical protocols, including sampling plans and endpoint definitions.
Expertise Areas
- Biomarker strategy and development
- Clinical biomarker integration
- Assay development and validation
- Translational medicine
Key Technologies
- Immunoassays
- PCR-based biomarker assays
- Assay validation protocols
- Biostatistical analysis